Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ZAI LAB LIMITED

(ZLAB)
  Report
Delayed Nasdaq  -  04:00 2022-10-05 pm EDT
37.07 USD   +1.28%
10/05Zai Lab Grants Share Options Under Equity Incentive Scheme
MT
09/29Zai Lab's H1 Loss Narrows to $220 Million; Shares Slip 6%
MT
09/28Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for TIVDAK
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Citigroup Adjusts Zai Lab Price Target to $193 From $198, Maintains Buy Rating

05/12/2022 | 09:56am EDT


© MT Newswires 2022
All news about ZAI LAB LIMITED
10/05Zai Lab Grants Share Options Under Equity Incentive Scheme
MT
09/29Zai Lab's H1 Loss Narrows to $220 Million; Shares Slip 6%
MT
09/28Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
AQ
09/28Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
AQ
09/28Zai Lab Strikes Licensing Deal with Nasdaq-listed Seagen for Cervical Cancer Drug
MT
09/27Zai Lab Signs Exclusive Collaboration, License Agreement With Seagen to Develop, Commer..
MT
09/27Zai Lab : Corporate Presentation
PU
09/27Zai Lab Ltd : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financ..
AQ
09/27Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
GL
09/27Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
CI
More news
Analyst Recommendations on ZAI LAB LIMITED
More recommendations
Financials (USD)
Sales 2022 221 M - -
Net income 2022 -468 M - -
Net cash 2022 796 M - -
P/E ratio 2022 -8,25x
Yield 2022 -
Capitalization 3 553 M 3 553 M -
EV / Sales 2022 12,5x
EV / Sales 2023 6,36x
Nbr of Employees 1 951
Free-Float 99,8%
Chart ZAI LAB LIMITED
Duration : Period :
Zai Lab Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZAI LAB LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 37,07 $
Average target price 93,57 $
Spread / Average Target 152%
EPS Revisions
Managers and Directors
Ying Du Chairman & Chief Executive Officer
Billy Cho Chief Financial Officer
Ning Xu Executive VP & Head-Clinical Operations
James Yan Chief Operating Officer-Research & Development
Joshua L. Smiley Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
ZAI LAB LIMITED-41.02%3 553
CSL LIMITED-0.08%90 424
SAMSUNG BIOLOGICS CO.,LTD.-10.63%40 403
BIOGEN INC.9.07%37 975
WUXI BIOLOGICS (CAYMAN) INC.-45.60%27 338
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-30.63%19 439